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Abstract
Murine models of urinary tract infection (UTI) have provided substantial data identifying uropathogenic E. coli (UPEC)
virulence factors and assessing their expression in vivo. However, it is unclear how gene expression in these animal models
compares to UPEC gene expression during UTI in humans. To address this, we used a UPEC strain CFT073-specific microarray
to measure global gene expression in eight E. coli isolates monitored directly from the urine of eight women presenting at a
clinic with bacteriuria. The resulting gene expression profiles were compared to those of the same E. coli isolates cultured
statically to exponential phase in pooled, sterilized human urine ex vivo. Known fitness factors, including iron acquisition
and peptide transport systems, were highly expressed during human UTI and support a model in which UPEC replicates
rapidly in vivo. While these findings were often consistent with previous data obtained from the murine UTI model, host-
specific differences were observed. Most strikingly, expression of type 1 fimbrial genes, which are among the most highly
expressed genes during murine experimental UTI and encode an essential virulence factor for this experimental model, was
undetectable in six of the eight E. coli strains from women with UTI. Despite the lack of type 1 fimbrial expression in the
urine samples, these E. coli isolates were generally capable of expressing type 1 fimbriae in vitro and highly upregulated
fimA upon experimental murine infection. The findings presented here provide insight into the metabolic and pathogenic
profile of UPEC in urine from women with UTI and represent the first transcriptome analysis for any pathogenic E. coli during
a naturally occurring infection in humans.
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Introduction
Animal models of infection have provided valuable insight into
diverse mechanisms of bacterial pathogenesis. Application of
microarray technology to these models has further enabled
analysis of bacterial global gene expression during infection of a
specific host. These studies have included transcriptional profiles
of pathogenic Escherichia coli in macrophages [1], host epithelial
cells [2], and mice [3,4]. More recently, a limited number of
groups have measured genome-wide expression of bacterial
pathogens during infections of a human host, including Vibrio
cholerae in rice water stool of cholera patients [5,6], Pseudomonas
aeruginosa in sputum from cystic fibrosis patients [7], and M.
tuberculosis in resected lung specimens [8]. When these data were
compared to results of animal model transcriptional studies, host-
specific differences were observed [8].
The urinary tract is among the most common sites of bacterial
infection in humans, and E. coli is by far the most common species
infecting this site, accounting for more than 80% of community-
acquired infections [9]. Uncomplicated UTIs include cystitis
infections in adult women who are not pregnant and do not suffer
from structural or neurological dysfunction [10]. Cystitis, a clinical
diagnosis presumed to represent infection of the bladder, is defined
by the presence of $10
3 bacteria/ml in a midstream, clean-catch
urine sample from a patient with symptoms including dysuria,
urinary urgency, and increased frequency [11,12]. Forty percent
of adult women will experience symptoms of cystitis during their
lifetime and there is a 25% risk that a second symptomatic episode
will occur within 6–12 months [13].
Uropathogenic E. coli (UPEC) represent a specific subset of E.
coli capable of colonizing the urinary tract and eliciting the
symptoms of cystitis and pyelonephritis. Genetically distinct from
commensal E. coli found in the intestinal tract, these strains contain
numerous genomic insertions into the ‘‘backbone’’ E. coli
chromosome, both as pathogenicity-associated islands (PAIs)
[14,15,16] and shorter islet sequences. In pyelonephritis isolate
CFT073, for example, genomic islands and islets comprise over
20% of the genome [14]. Acquired by horizontal gene transfer,
PAIs often encode proteins that contribute to pathogenesis; loss of
these regions may attenuate virulence [17,18].
An array of virulence and fitness factors has been described that
allow UPEC to access and persist in the urinary tract niche.
Flagellin-dependent motility is required for ascension to the
kidneys [19] and secreted toxins including hemolysin, cytotoxic
necrotizing factor 1, and secreted autotransporter toxin elicit
damage to the host epithelium [20,21,22]. Polysaccharide capsule
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urinary tract colonization and may allow immune evasion. Finally,
as the urinary tract represents a unique nutritional niche, TonB-
dependent metal acquisition systems are required for UPEC
survival in this iron-limited environment [25] and recent evidence
suggests that these pathogens metabolize peptides and amino acids
as a primary carbon source [26]. Transcriptome analysis of strain
CFT073 during murine experimental UTI demonstrated that
many of these fitness factors are upregulated during infection [4].
Perhaps the most well-defined UPEC virulence factors are type
1 fimbriae, adhesive structures required for complete colonization
of the murine urinary tract [27,28,29]. Encoded by virtually all E.
coli strains, type 1 fimbriae mediate urinary tract adherence via the
FimH fimbrial tip adhesin, which binds to mannosylated
uroplakins located on the uroepithelium surface [30]. This
interaction elicits a host response, including induction of pro-
apoptotic and epithelial differentiation factors [31], as well as
secretion of the pro-inflammatory cytokines interleukin-6 and IL-8
[32]. Expression of type 1 fimbriae is phase variable, controlled by
an invertible DNA element that contains the promoter for the
major structural subunit gene, fimA [33]. During murine
experimental UTI, fimA was the fourth most highly-expressed
gene and the other fim operon genes were also upregulated in vivo
as compared to in vitro culture [4].
To date, much of the work in this field has used E. coli strains
isolated from patients with UTI. The investigation of UPEC
pathogenesis, however, has largely been conducted using in vitro
models and the well established murine model of ascending UTI
[34]. Volunteer colonization studies utilizing a non-pathogenic
asymptomatic bacteriuria strain have shed light into mechanisms
that promote E. coli survival within the human urinary tract
[35,36], but do not represent UTIs caused by E. coli with full
pathogenic potential. If we wish to fill gaps in our understanding of
this widespread human pathogen, it is crucial to focus on UPEC
gene expression during naturally-occurring human UTI.
In this study, we measure gene expression in E. coli isolated
immediately following collection from the urine of eight women
experiencing symptoms of UTI. The data presented provide
insight into the metabolic and virulence profile of multiple UPEC
strains during human infection. We propose that E. coli utilizes an
array of iron acquisition systems and has access to plentiful carbon
sources during human UTI, allowing for robust replication and
may downregulate or transiently express a major virulence factor,
type 1 fimbria.
Results
Transcriptome analysis of E. coli UTI in urine from women
with UTI
Thirty-six urine samples were collected from 34 female patients
(ages 21–89, mean=47) attending a urology clinic with presump-
tive bacteriuria. Nineteen urine samples were culture-negative and
six specimens were culture-positive for bacterial species other than
E. coli, including coagulase-negative Staphylococcus sp. (n=2),
Acinetobacter baumannii (n=1), Enterobacter cloacae (n=1), Enterococcus
sp. (n=1), and Klebsiella pneumoniae (n=1). Eleven women were
culture-positive for E. coli and 10 of these specimens were suitable
for our study, as poor RNA yield prevented analysis of one E. coli
specimen. Of these ten E. coli-positive samples, two urine
specimens contained mixed infections of two different E. coli
strains. O and H serotyping conducted on these 12 E. coli isolates
indicated that O6 and O25, which are frequently associated with
UTI isolates [37], were the most common serogroups, represent-
ing 7 of 12 strains (Table S1). Two isolates (121 and 361), obtained
from the same patient on separate clinic visits (5 months apart),
had identical serotypes, but could not be conclusively identified as
the same strain. Antibiotic susceptibility testing indicated that
these clinical isolates also showed high frequencies (up to 7 of 12
isolates) of resistance to common UTI therapies, including
trimethoprim-sulfamethoxazole (Table S2).
Of the eight isolates ultimately used in our study (see below), all
were collected from pyuria-positive patients who were not
catheterized at the time of collection and 6 of 8 were collected
from patients reporting a previous UTI. Although these isolates
were obtained from urology patients, some with histories of UTI
or kidney stones, extensive genotype analysis compared against a
collection of over 300 E. coli isolates indicated that the virulence
gene profiles of these strains most closely matched other cystitis
isolates and not fecal-commensal E. coli (P. Vigil and H. Mobley, in
preparation).
CFT073-specific microarrays were used to measure transcript
levels from the eight E. coli isolates obtained from single-strain
infections, both immediately from the urine of infected women
and following static culture to mid-exponential phase in pooled
human urine ex vivo. Under each condition, 20–30% of all genes
measured (5379 ORFs) were classified as expressed for each isolate
(Table S3). It is important to note that genes classified as not
expressed may be absent or divergent in these strains.
UPEC replicates rapidly during human UTI
In all strains, the most highly expressed genes in urine from
women with UTI were those encoding ribosomal subunits. Indeed,
ribosomal genes comprised 24–54% of the top 50 most highly
expressed genes in each clinical isolate. It is well established that E.
coli rRNA and ribosomal protein mRNA synthesis increases
proportionally to growth rate [38,39]. Consistent with this, the
most highly expressed non-ribosomal genes also suggest rapid
bacterial growth in vivo (Table 1). Genes encoding transcription
and translation machinery (infC, yfiA, rpoA, rhoI, tufA, fusA, tufB, efp),
F0F1 ATPase components (atpE, atpF), fatty acid biosynthesis
factors (acpP, fabI), protein folding and secretion apparatus (slyD,
secG, prlA), and outer membrane components (ompA) were among
the most highly expressed during human infection.
Author Summary
Animal models of infection have been used extensively to
study how bacteria and other pathogens cause disease.
These models provide valuable information and have led
to the development of numerous vaccines and antimicro-
bial therapies. However, it is important to recognize how
these animal models compare to human infection and to
understand how bacteria cause disease in humans. This
study measured gene expression in E. coli, a major cause of
urinary tract infection, immediately after collection from
the urine of women with bladder infection symptoms. The
data showed that E. coli gene expression in the urine from
women with urinary tract infection was very often similar
to what had been observed in a mouse model, but these
studies also identified several potentially important
differences, including a bacterial surface structure that is
necessary for infection in mice but not detected in most E.
coli in human urine. Although more precise measurements
are still needed, these findings contribute to our under-
standing of bacterial infection in humans and will help in
the development of vaccines and treatments for urinary
tract infection.
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a.
Gene Annotation Median rank
b No. strains
c (n=8)
tufB Elongation factor Tu 88
rpoA DNA-directed RNA polymerase alpha chain 17 8
prlA Preprotein translocase SecY subunit 22 7
tufA Elongation factor Tu 23 8
fusA Elongation factor G 26 8
acpP Acyl carrier protein 34 8
yfjA 16S rRNA processing protein RimM 36 8
c1363 Hypothetical protein 38 8
atpE ATP synthase C chain 46 8
infC Translation initiation factor IF-3 49 8
ompA Outer membrane protein A precursor 53 8
c2114 Hypothetical protein 56 8
c0693 Hypothetical protein 64 6
rhoL Very hypothetical rho operon leader peptide 70 7
aceE Pyruvate dehydrogenase E1 component 71 6
cspA Cold shock protein A 71 5
secG Protein-export membrane protein 71 6
yceD Hypothetical protein 78 5
lpdA Dihydrolipoamide dehydrogenase 78 7
gapA Glyceraldehyde 3-phosphate dehydrogenase A 80 5
trmD tRNA (Guanine-N(1)-)-methyltransferase 80 5
ptsH Phosphocarrier protein HPr 80 6
tpiA Triosephosphate isomerase 81 6
ahpC Alkyl hydroperoxide reductase C22 protein 82 5
glnA Glutamine synthetase 83 5
c1040 Hypothetical protein 86 5
efp Elongation factor P 86 5
ydgR Putative tripeptide transporter permease TppB 89 5
atpF ATP synthase B chain 94 6
c4663 Hypothetical protein 96 4
yihK GTP-binding protein typA/BipA 96 5
yhdG tRNA-dihydrouridine synthase B 99 4
eno Enolase 100 4
cydA Cytochrome D ubiquinol oxidase subunit I 102 4
c4661 Hypothetical protein 102 4
slyD FKBP-type peptidyl-prolyl cis-trans isomerase 104 4
fis DNA-binding protein 104 4
fba Fructose-bisphosphate aldolase class II 105 4
rho Transcription termination factor Rho 105 4
fabI Enoyl-[acyl-carrier-protein] reductase [NADH] 110 4
ackA Acetate kinase 119 4
c4889 Hypothetical protein 144 4
chuA Outer membrane heme/hemoglobin receptor 205 4
aGenes encoding ribosomal subunits were excluded and only genes expressed by $4 strains are listed.
bGene expression rank (of 5379 ORFs) when genes listed in order of microarray signal intensity.
cNumber of strains for which indicated gene is among the top 50 non-ribosomal genes expressed in vivo. Gene may be expressed by other isolates (but not among top
50).
doi:10.1371/journal.ppat.1001187.t001
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prevented direct comparison between in vivo and in vitro conditions,
a more conservative, relative comparison was derived. To identify
expression differences between E. coli growth in urine during
cystitis and growth in urine ex vivo, genes were ranked in order of
microarray signal intensity, yielding an estimate of relative gene
expression. For each isolate, these rank values were compared
between in vivo and in vitro conditions. Genes for which the
expression rank significantly changed between these conditions
were considered differentially expressed.
Although we noted that two cold-shock-associated genes, cspA
and deaD, were upregulated in human urine samples (Table 2),
expression of cspA is known to occur during non-cold shock stress
conditions [40,41]. Moreover, both deaD and cspA were also
upregulated by UPEC [4] and an ABU strain [35] following
expulsion from the murine and human bladders, respectively.
Nevertheless, to assess the effect of temperature downshift that
may have occurred during sample processing, transcript levels of a
representative virulence gene, fimA, were measured after a urine
culture of strain CFT073 was moved from 37uC to room
temperature (Fig. S1). fimA transcript levels did not significantly
change after 10 min (or up to 60 min) at room temperature,
suggesting that sample processing was not responsible for these
results.
Cell division factors (ftsW, mraZ), tRNA processing and
translation machinery (rnpA, tgt, rplQ, rimP, truB, valS, gltX, yhdG,
ybeA, ycfB, lepA, ychf), and protein secretion components (secD, secF,
yidC) were among genes upregulated in vivo by the majority of
strains, suggesting that E. coli may be replicating faster in the
human urinary tract than in vitro (Table 2). Similarly, genes
involved in nucleotide synthesis (guaA, guaB, pyrG, pyrH), lipopoly-
saccharide assembly (lptF), peptidoglycan recycling (yjfG), and
enterobacterial common antigen synthesis (rfe) were also upregu-
lated. Taken together, these data indicate that E. coli was likely
replicating very rapidly during symptomatic UTI in women.
Microarray correlates with qPCR
To confirm these microarray findings, qPCR was performed
using in vivo- and in vitro-derived cDNA templates of two
representative E. coli strains isolated in this study, AL151 and
AL371. Strains were selected based on availability of in vivo cDNA.
The threshold cycle (Ct) values of the 13 genes measured (gapA,
hma, fyuA, fimA, papA_2, fliC, sat, sisA, glnA, gdhA, ackA, acs, and rplD)
correlated (P,0.001 or r,20.8431) with the normalized micro-
array signal intensities of each gene (Fig. 1A). Similarly, genes
identified as differentially expressed between in vivo and in vitro
conditions were consistently found to be up- or down-regulated in
these two strains by qPCR measurement (Fig. 1B). Finally, PCR
using in vivo-derived cDNA generally confirmed expression of
select virulence genes (Fig. 1C).
E. coli undergoes aerobic or microaerobic respiration
during human UTI
Genes involved in aerobic respiration tended to be highly
expressed by most strains assessed immediately after expulsion
from the human bladder. Encoding a component of cytochrome d
complex, which is maximally expressed during microaerobiosis,
cydA was among the top 50 most expressed non-ribosomal genes by
four isolates (Table 1) and was in the top 3% of genes expressed by
all strains in vivo and was similarly expressed during urine culture in
vitro. Expression of the cytochrome o oxidase genes cyoABCDE,
which are expressed in oxygen-rich conditions, varied among
patients. These genes were strongly expressed by 5 of 8 strains in
vivo (top 7%), more weakly expressed by 2 of 8 strains (top 20–
30%), and just below background in one strain. This is in contrast
to a recent E. coli transcriptome study for an asymptomatic
bacteriuria strain, which noted consistent downregulation of
cyoABCD during intentional colonization of the human bladder
[35]. For all strains, expression of cyoABCD and cydAB did not
appear to differ between in vivo and in vitro samples or from
expression by E. coli CFT073 during experimental infection of the
murine urinary tract [4], suggesting similar oxygenation in these
conditions.
Genes that encode a terminal electron acceptor pathway used
during anaerobiosis were not uniformly expressed by all strains.
For example, the genes encoding nitrate reductase I, narGHJIK,
were only expressed in vivo by two strains, AL121 and AL151.
Formate dehydrogenase N (fdnGHI), induced by nitrate [42] and
anaerobic conditions [43], was expressed by E. coli in half of UTI
patients (isolates AL121, AL151, AL291, and AL361). Nitrite-
inducible genes nirBDC were also expressed in half of patients
(isolates AL121, AL151, AL291, and AL371). Interestingly, the
three patient isolates that only weakly expressed cyoABCDE also
expressed nitrate reductase, formate dehydrogenase N, and nitrite
reductase, suggesting that these isolates likely experienced a more
anaerobic and nitrate/nitrite-rich environment and may be using
these products for anaerobic respiration. Together, these data
indicate that oxygen and/or nitrate levels in voided urine vary by
patient and suggest that pathogenic E. coli adapts to utilize either
form of respiration.
E. coli experiences nitrogen limitation in vivo
Previous transcriptomic analysis of E. coli indicated that the
murine urinary tract is nitrogen-limiting for this pathogen, despite
a high urea concentration in urine [4]. Glutamine synthetase
(glnA), which assimilates ammonia with high affinity in an energy-
dependent manner and is transcriptionally induced by nitrogen-
limited growth [44], was among the most highly expressed genes in
urine from 5 of 8 cystitis patients (Table 1). By qPCR, glnA was
upregulated in vivo (2.9-fold) in the two strains tested (AL151 and
AL371), while the low affinity energy-independent glutamate
dehydrogenase gdhA, which is transcriptionally repressed in low
nitrogen conditions [45], was downregulated 8.3-fold (Fig. 1B).
This indicates that E. coli similarly experiences nitrogen limitation
during infection of the human urinary tract. High concentrations
of nitrogen in urea are not available to the urease-negative E. coli.
Carbon metabolism suggests abundant carbon sources
in vivo
The gene encoding acetyl-CoA synthetase, acs, was one of the
most strongly downregulated genes in all E. coli strains during
growth in urine from women with UTI as compared to culture in
urine ex vivo (Table 3). Involved in acetate assimilation by
conversion to pyruvate, expression of this enzyme is activated by
decreasing oxygen and increasing cAMP levels [46]. In contrast,
genes involved in acetate excretion, shown to contribute to
urovirulence in a murine model [47], were strongly expressed in
vivo. The phosphate acetyltransferase (pta) gene was among the top
100 genes upregulated in vivo in 6 of 8 isolates (Table 2) and acetate
kinase (ackA) was one of the most highly expressed non-ribosomal
genes in 50% of the strains (Table 1). By qPCR, acs was
downregulated nearly 600-fold in vivo, while ackA was relatively
unchanged (Fig. 1B). Acetate-induced genes [48] glcBGD and the
glyoxylate shunt genes aceAB were also downregulated (Table 3).
Furthermore, components of the pyruvate dehydrogenase com-
plex, which functions upstream of AckA-Pta to convert pyruvate to
acetyl-CoA, aceE and lpdA were among the most highly in vivo
expressed genes in the majority of patient isolates (Table 1). These
UPEC Transcriptome in Urine from Women with UTI
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Gene Annotation Median D rank
a No. strains
b (n=8)
cspA Cold shock protein A 1260 8
c4376 Hypothetical protein (overlaps cspA on antisense strand) 1234 7
yhfC Uncharacterized transporter of major facilitator superfamily 1123 7
fis DNA-binding protein 1102 7
suhB Inositol-1-monophosphatase 1098 7
gltP Proton glutamate symport protein 1097 7
c5293 Hypothetical protein (overlaps rplI on antisense strand) 1076 6
ydgR Putative tripeptide transporter permease TppB 1071 8
yifK Probable amino acid or metabolite transport protein 1070 6
ndh NADH dehydrogenase II 1060 8
rplQ 50S ribosomal protein L17 1032 7
tgt Queuine tRNA-ribosyltransferase 1020 8
rnpA Ribonuclease P protein component 1009 8
deaD Cold-shock DEAD-box protein A 1000 7
yidC Putative inner membrane protein translocase component 967 8
guaB Inosine-59-monophosphate dehydrogenase 963 7
ptsG PTS system, glucose-specific IIBC component 922 6
yhdG tRNA-dihydrouridine synthase B 911 8
pyrH Uridylate kinase 908 7
brnQ Branched-chain amino acid transport system II carrier protein 903 7
secF Protein-export membrane protein 884 7
glnP Glutamine transport system permease protein 874 8
secD Protein-export membrane protein 869 6
carA Carbamoyl-phosphate synthase small chain 857 6
gidA Glucose inhibited division protein A 852 7
ychF GTP-dependent nucleic acid-binding protein EngD 849 7
ybeA rRNA large subunit methyltransferase 840 6
guaA GMP synthase [glutamine-hydrolyzing] 838 6
rfe Undecaprenyl-phosphatealpha-N-acetylglucosaminyltransferase 835 6
ybeB Hypothetical protein 819 7
ftsW Cell division protein FtsW 795 6
fldB Flavodoxin 2 795 6
yabB Cell division protein MraZ 792 7
yjfG UDP-N-acetylmuramate:L-alanyl-gamma-D-lutamyl-meso-diaminopimelate ligase 786 7
tig Trigger factor 785 7
pyrG CTP synthase 773 6
speE Spermidine synthase 761 6
yhbC Ribosome maturation protein RimP 758 8
truB tRNA pseudouridine synthase B 757 6
c0526 Hypothetical protein 757 6
yjgP LPS transporter inner membrane component LptF 741 6
ycfB tRNA(5-methylaminomethyl-2-thiouridylate)-methyltransferase 738 7
gltX Glutamyl-tRNA synthetase 719 6
c2839 Hypothetical protein (overlaps pta on antisense strand) 716 6
lepA GTP-binding elongation factor 715 6
valS Valyl-tRNA synthetase 690 6
pta Phosphate acetyltransferase 679 6
yqiA Esterase 634 6
aMedian change in relative expression rank (genes ranked in order of expression; highest, 1; lowest, 5379) in vitro compared to in vivo.
bNumber of strains for which indicated gene was among the 250 (4.6%) most upregulated genes. Gene may be expressed/upregulated by other strains, but wasn o t
among the top 4.6%.
doi:10.1371/journal.ppat.1001187.t002
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assimilate acetate during growth in the human bladder.
In bacteria, the acetate switch occurs when cells transition from
acetate dissimilation to assimilation. The expression of dissimilatory
genes by E. coli during infection of the human urinary tract indicates
not only that the bacteria have not yet reached stationary phase in
vivo, but also that they may be utilizing acetogenic carbon sources.
Acetogenesis occurs during mixed acid fermentation under
anaerobic conditions or aerobically when rapid growth on excess
carbonsourceslimitsfluxthroughthetricarboxylicacid (TCA)cycle
by excessive NADH production (reviewed in [49]). Because data
presented here support rapid aerobic or microaerobic growth of E.
coli during human UTI, this suggests that the observed acetogenesis
is due to ‘‘overflow metabolism’’ and not mixed acid fermentation.
This further implies that easily assimilable carbon sources are
available to UPEC during symptomatic UTI.
Peptides and amino acids have been previously implicated as
primary carbon sources for UPEC during colonization of the
murine urinary tract [26]. Di- and oligopeptide transport
components dppA and oppA, shown previously to contribute to
UPEC virulence [26], were strongly expressed by all strains during
UTI in women (Fig. 2A). Additionally, a putative tripeptide
transporter, ygdR (tppB), was upregulated in vivo by all E. coli isolates
(Table 2) and was among the top 50 most highly expressed non-
ribosomal genes in 5 of 8 strains (Table 1). Other amino acid or
metabolite transporters, yifK, yhfC, and brnQ were also upregulated
in vivo. These findings suggest that E. coli may use peptides as an
energy source during human UTI, as well.
When compared to culture in urine ex vivo, E. coli in voided urine
from UTI patients downregulated a number of genes involved in
metabolic functions (Table 3). The talA gene, which encodes one of
two transaldolases in the E. coli pentose phosphate pathway and
does not to contribute to UPEC fitness in a murine model [26], was
downregulated. Consistent with rapid growth and TCA cycle
saturation, genes in this pathway (sdhB, acnA, and fumA)a sw e l la sa-
ketoglutarate permease (kgtP), which imports a TCA cycle
intermediate, were also downregulated. Indeed, growth on excess
glucose (an easily assimilable carbon source) has long been
appreciated to inhibit expression of sdhAB [50] and the succinyl-
CoA synthetase complex (reviewed in [49]). Overall, dehydroge-
nase-type enzymes were frequently downregulated in vivo compared
to growth in vitro, consistent with the hypothesis that rapid growth in
vivo requires E. coli to adapt by modifying the TCA cycle to
optimally regenerate NAD
+. Together, the finding that genes
involved in acetogenic growth, peptide import, and the TCA cycle
are expressed or modulated during human cystitis is consistent with
the requirement of these pathways for UPEC virulence and support
the current model of UPEC metabolism during UTI [26,47].
Virulence gene expression in vivo
While a number of studies have assessed expression of UPEC
virulence genes during experimental infection of animal models
Figure 1. E. coli gene expression in voided urine from cystitis patients and culture in urine ex vivo. (A) Correlation of gene expression
levels obtained by microarray and qPCR. Ct values determined by qPCR are plotted for 13 genes (see text) versus normalized microarray signal
intensity for in vivo (left two panels) and in vitro (right two panels) cDNA samples from patient isolates 371 (first and third panel) and 151 (second and
last panel). Correlation coefficient (r) values are shown and P,0.001 for all correlations. (B) Genes differentially expressed during UTI in women and
culture in urine ex vivo. Log2 fold changes in vivo, compared to in vitro expression, were measured by qPCR and are normalized to gapA transcript. (C)
Confirmation of in vivo gene expression by clinical isolates as shown by PCR using genomic DNA or cDNA template.
doi:10.1371/journal.ppat.1001187.g001
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Gene
a Annotation Median D rank
b No. strains
c (n=8)
glcB Malate synthase G 21730 7
glcG Protein glcG 21715 7
osmC Osmotically inducible protein C 21705 8
glcD Glycolate oxidase subunit 21700 8
ilvB Acetolactate synthase isozyme I large subunit 21673 7
c2623 Fructose-bisphosphate aldolase class I 21647 8
osmY Osmotically inducible protein Y precursor 21637 8
aceB Malate synthase A 21634 8
yjcG Putative symporter 21622 8
ygjG Probable ornithine aminotransferase 21619 8
amyA Cytoplasmic alpha-amylase 21608 8
phoH PhoH protein 21603 8
aceA Isocitrate lyase 21585 7
rpsV 30S ribosomal protein S22 21563 8
leuD 3-isopropylmalate dehydratase small subunit 21553 7
aldB Aldehyde dehydrogenase B 21550 8
aldA Aldehyde dehydrogenase A 21550 8
mglB D-galactose-binding periplasmic protein precursor 21548 8
acs Acetyl-coenzyme A synthetase 21548 8
leuC 3-isopropylmalate dehydratase large subunit 21545 8
leuA 2-isopropylmalate synthase 21526 8
wrbA Flavoprotein 21519 8
yiaK Hypothetical oxidoreductase 21512 7
msyB Acidic protein msyB 21500 8
elaB ElaB protein 21488 8
yhiO Universal stress protein B 21481 7
adhP Alcohol dehydrogenase, propanol-preferring 21459 7
dadA D-amino acid dehydrogenase small subunit 21449 7
ecnB Putative toxin of osmotically regulated toxin-antitoxin 21443 8
sgbU Putative hexulose-6-phosphate isomerase 21436 7
potF Putrescine-binding periplasmic protein precursor 21429 7
sbmC DNA gyrase inhibitory protein 21400 8
talA Transaldolase A 21399 7
leuB 3-isopropylmalate dehydrogenase 21397 7
ppsA Phosphoenolpyruvate synthase 21378 8
fumA Fumarate hydratase class I, aerobic 21372 7
acnA Aconitate hydratase 1 21364 8
kgtP Alpha-ketoglutarate permease 21363 8
potH Putrescine transport system permease protein 21360 7
rspB Starvation sensing protein 21350 7
ytfQ ABC transporter periplasmic binding protein 21347 7
hdhA 7-alpha-hydroxysteroid dehydrogenase 21347 8
treA Periplasmic trehalase precursor 21347 7
c1843 Putative glyceraldehyde 3-phosphate dehydrogenase C 21321 7
araH High-affinity L-arabinose transport system 21247 8
sdhB Succinate dehydrogenase iron-sulfur protein 21241 7
bolA BolA protein 21239 7
yqeF Probable acetyl-CoA acetyltransferase 21232 7
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a Annotation Median D rank
b No. strains
c (n=8)
c3746 2,5-diketo-D-gluconic acid reductase A 21223 8
ybaT Hypothetical transport protein 21202 7
ybaS Probable glutaminase 21184 7
cbpA Curved DNA-binding protein 21048 8
cspD Cold shock-like protein 2941 7
aGenes with annotated functions are shown. Downregulated hypothetical genes are shown in Table S4.
bMedian change in relative expression rank (genes ranked in order of expression; highest, 1; lowest, 5379) in vitro compared to in vivo.
cNumber of strains for which indicated gene was among the 250 (4.6%) most downregulated genes. Gene may be downregulated by other strains, but was not among
the top 4.6%.
doi:10.1371/journal.ppat.1001187.t003
Table 3. Cont.
Figure 2. E. coli virulence factor expression in urines from UTI patients. Heat maps indicate normalized microarray signal intensities for
genes encoding (A) UPEC fitness factors and (B) genes in the fim locus in eight E. coli isolates in urine collected from women with cystitis. For
reference, the overall most (rpsK, +) and least (pheM, 2) expressed genes are shown in the bottom panels, representing average signal intensities of
15.821 and 3.881, respectively.
doi:10.1371/journal.ppat.1001187.g002
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human infection. These microarray data show most strikingly that
the expression of genes involved in adherence to host tissues that
are highly expressed during murine infection [4], was not detected
in the majority of patient isolates (Fig. 2A). Genes encoding P,
F1C, or Auf fimbriae were not expressed (i.e., below background)
in any E. coli strains after expulsion from the human urinary tract
or gene absence/divergence otherwise prevented detection of
these transcripts. Furthermore, the type 1 fimbrial adhesin fimH,
which is required for virulence during murine infection [27,28]
and invasion [29], was only expressed at detectable levels by E. coli
in 2 of 8 patients. These strains, AL231 and AL241, also expressed
the remaining genes in the fim locus, while the other six strains did
not (Fig. 2B). To validate these microarray findings, PCR was
performed on in vivo-isolated cDNA from all strains except AL051
and AL121 (for which no in vivo-derived cDNA sample remained).
This confirmed the expression of the major structural subunit fimA
only by strains AL231 and AL241, as well as lack of P fimbrial
(papA_2) gene expression by strains AL151, AL241, AL361, and
AL371 (Fig. 1C). Strains AL231 and AL241, which were shown to
express fimA in vivo by RT-PCR (Fig. 1C), encoded genes that were
90% identical to fimACFT073 (Fig. S4). Because fimA transcripts
were not detected by microarray for these strains (Fig. 2), we can
conclude that our microarray hybridization conditions required
greater than 90% sequence identity to yield signal significantly
above background. PCR results for additional virulence genes
were also generally consistent with their expression by microarray
(Fig. 1C, Fig. 2A).
Few patient isolates appeared to express toxin-encoding genes
with significant sequence identity to CFT073 toxins above
background levels in vivo (Fig. 2A). Two isolates expressed sat or
genes encoding the non-ribosomal peptide/polyketide colibactin
significantly above background and expression of both colibactin
and tsh was only detected in a single isolate (strain AL291).
Consistent with transcriptome data from murine UTI [4], flagellin
(fliC) gene expression was downregulated in vivo, as compared to in
vitro culture (Fig. 1B).
As alluded to above, metabolic pathways have also been
implicated in UPEC virulence. The central metabolic pathways of
gluconeogenesis and the TCA cycle are required for UPEC fitness
in the murine urinary tract [26] and sdhB, pckA and tpiA, encoding
enzymes in these pathways, although downregulated compared to
growth in vitro, were nonetheless expressed in all patient isolates
(Fig. 2A). Other metabolic genes implicated in urovirulence,
including guaA and argC [52] were also expressed in vivo by all E. coli
strains and guaA was upregulated relative to culture in urine ex vivo
(Table 2). Expression of D-serine dehydratase (dsdA), which
processes the putative metabolite signal D-serine [53], was
detected in half of the bladder-expelled E. coli strains measured.
Genes involved in siderophore production and iron acquisition
were globally the most highly expressed fitness determinants across
all eight isolates following infection of the human urinary tract. All
isolates robustly expressed tonB, fepA, and fyuA, although genes for
the synthesis of enterobactin and yersiniabactin siderophores were
sporadically detected, possibly due to inherently lower transcript
levels for these enzymes (Fig. 2A). Nearly all (7 of 8) strains
expressed the heme receptor-encoding chuA and in half of patients,
this gene was among top 50 most highly expressed non-ribosomal
genes (Table 1). In contrast, the heme receptor hma was expressed
above background in just 4 of 8 patient isolates. In vivo expression
of genes for the salmochelin receptor iroN and aerobactin receptor
iutA was only observed in two isolates, while receptor genes ireA,
fpbA1 and fbpA2 were not expressed by any strains, either in vivo or
in vitro. Despite these differences, all strains were capable of growth
in vitro under iron-limiting culture conditions in the presence of the
chelator 292-dipyridyl (200 mM), although strains AL231 and
AL241 could not replicate under more stringent iron-limitation
(400 mM) (Fig. S2). These data provide further support for the
well-established model of the human urinary tract as an iron-
limiting environment [4,25,35].
Interestingly, in vivo and in vitro expression of iron uptake systems
did not always correlate and isolates occasionally expressed a
specific system in only one condition. For example, patient isolates
AL121 and AL241 expressed genes coding for yersiniabactin
production only during in vitro culture, while strain AL231
expressed these genes strictly during in vivo conditions (Fig. S3).
For strain AL231, poor in vitro expression of these and other genes
involved in iron acquisition (including fep/ent and iro loci)
correlated with the strain’s inability to replicate under stringent
iron limitation (Fig. S2). This apparent differential expression of
iron uptake genes implies that the extent of iron limitation (and by
implication, Fur regulation) differs among individual patients, as
well as between the human bladder and urine ex vivo. Furthermore,
it suggests additional regulation of iron acquisition systems during
E. coli infection; indeed oxygen tension has been shown to affect
expression of iron uptake genes by other pathogens [54].
Pathogen-specific genes expressed during human cystitis
A subset of fitness genes expressed by E. coli following infection
of the human urinary tract was specific to pathogenic E. coli. That
is, these genes are absent from the fecal-commensal E. coli strain
K12, suggesting that they represent horizontally-acquired, putative
fitness genes. Iron acquisition components (fyuA, chuA, chuS, chuW,
chuX), capsule synthesis genes (kpsF, kpsD, kpsU, kpsC), an
inflammatory suppressor (sisA), a PAI-associated prophage inte-
grase gene (c2418), and several hypothetical genes were expressed
by the majority of UPEC patient isolates in vivo (Table 4). These
data indicate that the patient isolates examined here express an
array of pathogen-specific genes in vivo and further imply that they
indeed represent pathogenic E. coli strains.
Expression of iron uptake and metabolic genes, but not
adhesin genes, is similar in voided urine from murine and
human UTI
To compare UPEC virulence gene expression in different
mammalian hosts, relative expression levels of 46 fitness genes by
CFT073 following experimental murine UTI (derived from [4])
were compared to the average relative expression levels (average
expression rank) by E. coli patient isolates following human UTI.
Overall, relative UPEC virulence gene expression in mice
positively correlated with expression in a human host (Spearman
r=0.5890; P,0.0001). Genes involved in iron acquisition and
metabolism correlated most strongly between the two data sets,
with most having less than 10% difference in relative (ranked)
expression (Fig. 3). fyuA was the exception, due to its poor
expression by CFT073 [4], likely attributed to mutations
preventing yersiniabactin production [15,55]. Expression of
toxin-encoding genes was moderately similar in expelled urine of
the two hosts, differing by only 30–50%. In contrast, adhesin and
fimbriae expression was quite different between human and
murine urine, with most genes having more than 50% relative
expression difference between the two hosts. For example, fimA
was the fourth most highly expressed gene (relative expression
value: 5375) by E. coli CFT073 during murine infection, while it
had an average rank of 3873 out of 5379 ORFs in women with
UTI (relative expression value: 1506).
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Surprisingly, we found that most (6 of 8) E. coli isolates did not
express type 1 fimbriae in the urine of patients with UTI. One
possible explanation is that these strains do not encode intact type
1 fimbrial genes or that expression of these genes is defective. To
distinguish among these possibilities, we examined expression of
type 1 fimbriae in vitro by the 8 clinical isolates. Using a PCR-based
assay (Fig. 4A), we determined the orientation of the fim invertible
element, the 314 bp region that contains the promoter for the
major structural subunit fimA and is responsible for phase variation
of type 1 fimbriae [33]. As expected, after two 48 h static passages
to enrich for type 1 fimbriae expression, all strain populations
consisted of bacteria in both the phase-on and phase-off
orientations (Fig. 4B). In contrast, when isolates were cultured
with aeration for 4 h, only the phase-off orientation could be
detected. Invertible element orientations correlated with detection
of FimA by western blot (Fig. 4C). Except for strain AL051, from
which neither fimA nor the invertible element could be PCR-
amplified, all strains expressed an approximately14 kDa protein
that reacted with antiserum raised against FimACFT073. Band
intensity may reflect differences in expression level among strains
or, more likely, differences in antibody reactivity to diverse FimA
antigens. Indeed, the nucleotide sequences of the fimA genes of the
clinical isolates are 90–99% identical to fimACFT073, with strain
AL371 having the highest identity (Fig. S4).
Finally, to assess the assembly of functional fimbriae, the ability
of these isolates to agglutinate guinea pig erythrocytes in a
mannose-sensitive manner was measured. With the exception
again of AL051, all strains exhibited some degree of mannose-
sensitive hemagglutination, indicative of type 1 fimbrial produc-
tion (Fig. 4D). Strain AL371 consistently displayed weak, but
detectable hemagglutination. Together, these data demonstrate
that, although expression of type 1 fimbrial genes was generally
not detected in the urines of cystitis patients, 7 of 8 clinical E. coli
isolates obtained from women with UTI are capable of
appropriately expressing functional type 1 fimbriae in vitro.
Clinical UPEC isolates upregulate fimA during murine UTI
The transcriptome analyses presented in this study identified
genes differentially expressed in the urine of different mammalian
hosts (Fig. 3). However, these data were obtained by comparing
the expression of E. coli clinical isolates following collection from
human UTI with E. coli strain CFT073 expression during murine
experimental UTI. As a result, the expression incongruencies
could be due to inherent strain-specific differences that exist
between the model E. coli strain CFT073 and the clinical isolates
collected from infected women. To address this, the isolates
(except for Fim
2 strain AL051) were tested in the murine model of
ascending UTI. Unlike fecal strain EFC4, which was shown
previously to have low infectivity in mice [56], all isolates except
AL241 colonized the bladders of CBA/J mice (Fig. 5A and data
not shown).
To directly compare the gene expression of a single strain after
its colonization of the human and murine urinary tracts, urine was
collected and pooled throughout the 48 h infection for strains
AL151 and AL371 and transcripts isolated from these pooled
samples were quantified by qPCR. In contrast to human infection,
both clinical isolates strongly upregulated fimA in the urine of
infected mice (Fig. 5B). Relative to expression during human UTI,
fimA was upregulated 660- and 640-fold in the murine bladder by
strains AL151 and AL371, respectively. These data, which reflect
the change in relative expression rank between murine and human
infection (Fig. 3), indicate not only that strains AL151 and AL371
are capable of expressing type 1 fimbriae in vitro, but that they
robustly express fimA during murine UTI. Thus, it appears that
these E. coli strains had downregulated type 1 fimbriae in the urine
of women with cystitis.
Discussion
Here we report, for the first time, the transcriptional profile for
any pathogenic E. coli following a naturally-occurring human
infection. This study represents the largest number of subjects for
any human transcriptome study and includes the largest number
of bacterial strains studied in such experiments. Our data suggest
that E. coli had access to abundant carbon sources prior to
expulsion from the human bladder and replicates rapidly,
expressing genes involved in nitrogen assimilation, iron acquisi-
tion, and virulence, while variably expressing or downregulating at
least one major adhesin as assessed in voided urine at the time of
sample collection.
Although the women sampled have a history of recurrent UTI,
our data suggest that the E. coli strains measured in this study
represent UPEC strains with full pathogenic potential. All strains
were able to colonize a mouse model of ascending UTI, unlike
fecal-commensal E. coli, and genotype analysis classified them with
normal cystitis strains (P. Vigil and H. Mobley, in preparation). All
patients in the present study had pyuria, indicating the presence of
a robust inflammatory response, which is generally absent in
patients with asymptomatic bacteriuria [57]. Nonetheless, it is
important to note that the data presented here indeed represent a
limited sampling of patients and future studies should expand this
analysis to a larger population.
Table 4. Pathogen-specific
a genes expressed in the majority
of urines from women with UTI.
Gene Product/function
No. strains
b
(n=8)
c0222 Hypothetical protein 7
c2418* Prophage P4 integrase 7
fyuA* Yersiniabactin receptor precursor 7
c2484* Hypothetical protein YbdM 6
sisA shiA-like inflammation suppressor A 6
c3686* Hypothetical protein YrbH (KpsF) 7
kpsD Polysialic acid transport protein KpsD 7
c3689 3-deoxy-manno-octolusonate transferase KpsU 6
kpsC Capsule polysaccharide export protein KpsC 6
c4222 Putative DNA processing protein 6
chuS* Putative heme/hemoglobin transport protein 6
chuA* Outer membrane heme/hemoglobin receptor 7
chuW* Putative heme oxygenase 6
chuX* Hypothetical protein 7
rfaP LPS core biosynthesis protein 7
rfaG LPS core biosynthesis protein 7
rfaQ LPS core biosynthesis glycosyltransferase 7
c5060* Hypothetical protein 6
aPathogen-specific is defined as genes absent from E. coli K12 strain MG1655.
bNumber of patient isolates for which the indicated gene is considered
expressed (microarray signal intensity is at least four-fold above background).
*Indicates genes present in 10/10 UPEC isolates and 0/3 fecal E. coli isolates as
determined by comparative genomic hybridization [88].
doi:10.1371/journal.ppat.1001187.t004
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virulence determinants across all eight patient isolates in vivo.I n
addition to bacteria isolated from urine, we and other groups have
observed expression of outer membrane iron receptors by bladder
cell-associated UPEC, both in vitro [58] and in vivo [51]. Iron
acquisition is required for urinary tract colonization [25] and
UPEC isolates produce siderophores that are not synthesized by
most non-pathogenic fecal E. coli strains [59]. Consequently, outer
membrane iron receptors have been examined as targets of a
vaccine to protect against E. coli UTI [60,61]. Data presented here
indicate that at least one protective antigen, Hma, is expressed by
at least half of E. coli populations during expulsion from the human
urinary tract. Of note, the antigen that generated the highest IgA
titer, IreA, was not expressed by any patient isolate examined,
while the non-protective antigen ChuA was among the most
highly expressed genes in all strains. It is interesting to speculate
that pressure from the host adaptive immune response may
represent negative selection against these genes and/or their
regulatory elements.
Despite the iron- and nitrogen-limiting conditions within the
human urinary tract, our data support a model of robust UPEC
replication during infection. When rapid growth and excess
reducing equivalents (NADH and FADH2) impose a limitation on
the oxidative-dependent TCA cycle, acetate can be excreted to
maintain redox homeostasis and recycle coenzyme A [49].
Recently, Welch and colleagues demonstrated that UPEC is
better adapted to acetogenic growth than E. coli K12 and showed
that mutants defective in acetate dissimilation (pta and ackA) had
reduced fitness during murine UTI, while a mutant defective in
acetate assimilation (acs) did not [47]. Our data support these
findings and suggest that UPEC is undergoing similar growth and
metabolism during human cystitis. Furthermore, this implies that
acetyl-phosphate, which accumulates during acetogenic growth
and can act as an intracellular signal, could play a role in UPEC
Figure 3. Host-specific virulence gene expression by E. coli. Relative virulence and fitness gene expression by E. coli isolates in urine from
human UTI plotted versus relative expression by E. coli CFT073 in urine from experimental murine UTI. Line shows the theoretical perfect correlation.
Panels highlight fitness genes encoding adherence and motility factors (top left), toxins (top right), iron acquisition systems (bottom left), and
metabolic and transport proteins (bottom right). Relative expression is based on normalized microarray signal intensity rank (1, gene with lowest
signal; 5379, gene with highest signal). Relative human expression is the median rank of all eight isolates, except for fimA, papA, papA_2, hlyA, sat, pic,
tsh, tosA, chuA, iutA, iroN, fyuA, hma, iha, and sitA, which are medians from isolates positive for given gene by PCR (P. Vigil and H. Mobley, in
preparation). Highlighted genes are colored to indicate the expression rank difference of each gene between human and murine UTI: red, less than
10% difference in expression rank; orange, 10–30% difference; green, 30–50% difference; blue, greater than 50% difference. Spearman rank
correlation coefficient for all genes is r=0.5890 (P,0.0001). Murine data were derived from our previously-published transcriptome study [4].
doi:10.1371/journal.ppat.1001187.g003
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differential expression of a number of metabolic genes, flux
through these pathways is often regulated posttranscriptionally by
enzyme activity and allosteric mechanisms [62,63], so it is not
surprising that a complete metabolic profile cannot be detailed
solely from transcriptional data.
Our data suggest that growth of E. coli in the human urinary
tract is similar to its replication in a chemostat culture. Urine has
been described as a mixture of small peptides and amino acids [64]
and urine production by the kidneys assures that this medium is
continuously replenished. Thus, in contrast to culture in urine ex
vivo, E. coli in the human urinary tract likely has constant access to
easily assimilable carbon sources. These results also imply that,
although nitrogen and iron are limiting in this environment, E. coli
acquires adequate quantities of these elements for robust
replication.
Whether E. coli present in voided urine accurately represent the
physiological state of the bacteria attached to and within the
bladder mucosa is unclear [65]. Because the majority of UTI
pathogenesis occurs on the bladder epithelium, the critical
contribution of adherent bacteria is apparent. In contrast, the
pathogenic contribution of luminal E. coli, which are diagnostic for
UTI, is largely undefined. While several groups have measured
global gene expression by various E. coli strains in urine from
infected mice [3,4] and humans [35], the transcriptome of
bladder-associated UPEC has not yet been described and is
obviously not feasible in human patients. However, genes
identified as highly expressed or upregulated in the urine of
Figure 4. In vitro expression of type 1 fimbriae by clinical E. coli isolates. (A) Invertible element (IE) assay for type 1 fimbriae [73]. IE is shown
in gray; inverted repeats (IR) located within the IE; orientation of the fim promoter (P) indicated by arrow in phase-on (top panel) and phase-off
(bottom panel) positions. Expected fragment sizes following PCR (half arrows show primer sites) and asymmetrical SnaBI digest are indicated by black
bars. (B) IE orientation determined as described in (A) for strains cultured statically under type 1 fimbriae-enriching conditions or with aeration.
Arrows indicate expected sizes for phase-on and phase-off. CFT073 strains with mutations preventing IE switching and locking the ‘‘phase-on’’ (L-ON)
or ‘‘phase-off’’ (L-OFF) orientation are also included. M, molecular mass standards; sizes (in kb) are indicated. (C) Western blot using anti-FimA
polyclonal antibody. Strains were cultured as in (B) and acid-treated whole cell lysate separated on 15% SDS-PAGE gels. Top panel, type 1 fimbriae-
enriching static culture; bottom panel, aerated culture. Arrows indicate the ,12 kDa FimA band. (D) Mannose-sensitive hemagglutination. Strains
were cultured as in (B) (statically, top two rows; aeration, bottom two rows) and their ability to agglutinate guinea pig erythrocytes in the presence (+)
or absence (2) of alpha-methyl-mannoside (a mm) was assessed. 2, no agglutination; +/2, weak agglutination; +, agglutination with undiluted or 1:2
dilution of bacterial suspension; ++, agglutination with 1:4 or 1:8 dilution; +++, agglutination with 1:16 or 1:32 dilution; ND, not determined. Data
represent median agglutination reactions of three independent experiments.
doi:10.1371/journal.ppat.1001187.g004
Figure 5. Murine colonization and type 1 fimbriae expression
by clinical isolates. CBA/J mice were transurethrally inoculated with
10
8 CFU E. coli EFC4 (fecal strain), CFT073 (model pyelonephritis strain),
or clinical isolates AL371 or AL151. (A) Bladder colonization at 48 hpi.
Symbols represent data from individual animals and bars indicate the
median. (B) fimA expression by isolates AL371 (gray bars) and AL151
(black bars) during murine UTI. Urine was collected from infected mice
6–48 hpi and transcript levels from expelled bacteria measured by
qPCR. For each strain, urines were pooled from five mice (n=10) and
represent two biological replicates. Expression fold change following
expulsion from the murine bladder relative to expression following
expulsion from the human bladder is shown.
doi:10.1371/journal.ppat.1001187.g005
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[4], frequently have roles in colonization [25,28,66,67], suggesting
that these genes are expressed at some point during association
with the murine bladder. Furthermore, qPCR analysis of laser-
capture microdissected UPEC from within urothelial cells of
infected mice showed increased expression of ferric iron
acquisition genes, including the heme receptor chuA [51]. These
data are consistent with our transcriptome studies of experimental
[4] and natural UTI; both identified chuA as one of the most highly
expressed genes in the urine of infected mice and cystitis patients.
Taken together, these studies strongly suggest that, at least in mice,
voided urine represents a reasonable estimate of virulence gene
expression during cystitis.
Surprisingly, none of the major adherence factors described
for UPEC were appreciably expressed in bacteria in urine
voided from the human bladder. Because surface structures like
fimbriae are known to vary antigenically, sequence dissimilar-
ities between the clinical isolates tested and the UPEC genome
represented on the microarray likely contributed at least
partially to the low fimbrial detection. Indeed, for type 1
f i m b r i a e ,s e q u e n c ed i v e r g e n c ea p p e a r e dt oa c c o u n tf o rt h el o w
detection of the major structural subunit gene fimA, as transcript
could not be detected for any isolate by microarray, while strains
AL231 and AL241 were shown to express this gene by qPCR.
However, expression of the remaining fim locus was indeed
detected for these two patient isolates (AL231 and AL241),
indicating that these genes may be more conserved. Similarly, at
least four patient isolates encode the major P fimbrial subunit
papA_2 (AL151, AL241, AL361, AL371), but neither microarray
nor qPCR could detect papA_2 transcript in the corresponding in
vivo samples. Although not critical for virulence in a murine
model of infection [68], P fimbriae have long been associated
with pyelonephritis in humans [37]. Indeed, E. coli that react
with anti-P fimbrial antibodies can be isolated from the urine of
patients with UTI [69,70,71]. The fact that P fimbrial gene
expression was not detected in our patient isolates may be
due to temporal or localized expression of these genes, or a
result of our focus on patients with cystitis, rather than
pyelonephritis.
Data from previous studies have implied expression of type 1
fimbriae by a small or variable subset of E. coli in human urine.
Indirect immunofluorescence of bacteria present in urine of
patients with acute UTI has yielded varied results with respect to
type 1 fimbrial detection. Several studies identified type 1
fimbriate cells in less than 38% [70] or 45% [72] of urine
samples, but nearly in 100% of the same isolates following in vitro
culture, while another group observed type 1 fimbriate cells in
76% of urine specimens [69]. Experiments from our laboratory
quantified the type 1 fimbrial invertible element switch orientation
in a bacterial population collected directly from the urine of 11
women with E. coli UTI. In that study, the switch was primarily in
the ‘‘off’’ position within this population; for all 11 cases, bacteria
in patient urine averaged only 4% ‘‘on’’ [73]. While there appears
to be some variation among patient populations, these findings are
overall consistent with our observation that only 25% of E. coli
isolates expressed type 1 fimbrial genes in urine collected from
cystitis patients.
Several models could account for our finding that the majority
of E. coli are not transcriptionally active for type 1 fimbriae in urine
collected from cystitis patients. First, it is possible that E. coli
present in voided urine represent the nonadherent ‘‘losing’’
fraction of the population that is expelled from the bladder.
However, the samples used in our microarray were not processed
to remove exfoliated epithelial cells, so it is likely that both
planktonic and adherent bacteria were present to some extent and
that neither population significantly expressed type 1 fimbriae.
Moreover, measurement of the UPEC transcriptome during
murine UTI also relied on the collection of expelled urine from
infected animals and those data identified fimA as the fourth most
highly in vivo-expressed gene. Nonetheless, adhesin gene expression
differences between adherent and planktonic E. coli during human
infection likely contributed to our results and should be further
examined in future studies.
The duration of infection likely also contributed at least
somewhat to our variable detection of fimbriae expression. Urine
was collected from mice infected with strains AL151 and AL371
from 6–48 hpi (Fig. 5), while it is unknown how long the women in
this study were colonized at the time of sample collection.
Although it is well-established that type 1 fimbriae are critical for
the establishment of infection in mice [28,74], their role during
bacterial persistence has not been characterized. Consequently,
the human urine samples collected in this study may have
represented later stages of UTI, during which type 1 fimbrial genes
may not be expressed or after fimbriated cells had been cleared by
the immune system. In a mouse model of UTI, the orientation of
the fim invertible element varied throughout the course of infection
and by strain, with cystitis strains generally maintaining their IEs
in the phase-on position throughout the infection (up to 96 hpi)
[75]. Similarly, expression of type 1 fimbriae was shown to be
required for UPEC fitness subsequent to the initial attachment/
invasion event in a murine model of intracellular replication [76].
Furthermore, transcriptome analysis of UPEC during murine UTI
analyzed urine collected up to 10 days post-infection (with a
reinfection at day 6) and still observed a high level of fim expression
[4], so it is unclear whether infection duration alone can explain
our results. Nevertheless, future studies should attempt to correlate
UTI symptom duration with type 1 fimbrial gene expression of E.
coli collected from human urine.
Given the abundance of data from our and other laboratories
demonstrating the importance of type 1 fimbriae for UTI
[27,28,29,77] and positive selection for fimH among UTI isolates
[16], a likely explanation for our findings is that expression of these
genes may be a transient or regulated event during human
infection. Analogous to flagellin, which is tightly regulated and
only maximally expressed during ascension to the kidneys [19], fim
expression might be temporally or spatially controlled. We may
speculate that, while phase-on bacteria would be primed to adhere
to and invade the bladder epithelium, perhaps switching to the
phase-off orientation allows dispersal or immune avoidance. Thus,
future delineation of the molecular basis for the apparent variable
type 1 fimbriae expression detected in our samples, as well as
distinction between global gene expression in planktonic versus
adherent bacteria in urine voided during human UTI will be
necessary.
Differences in urinary tract environments among patients and
between mammalian hosts are also expected to account for some
of the variable expression patterns observed in this study. Diet,
hydration, and genetic factors all influence urine composition,
urinary tract physiology and, most likely, gene expression by
colonizing bacteria. For example, amino acids, temperature [78],
sialic acid [79], oxygenation [80], pH and osmolarity [81] are
known to affect the orientation of the invertible element region
and thus, fimbrial expression. As the present study represents an
initial investigation of UPEC gene expression during human UTI,
further analysis of additional patient samples will be needed to
more completely assess potential correlations between urine
chemistry and UPEC gene expression in urine from patients with
UTI.
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pathogenic E. coli gene expression within the human host. Our
findings are generally consistent with data generated using murine
models and support the current model of UPEC pathogenesis. In
urine from women with cystitis, E. coli express metabolic genes
consistent with rapid replication and acetate excretion, actively
scavenge iron, express known virulence genes, and may modulate
expression of genes involved in motility and adherence. Continued
investigation of UPEC gene expression in the urine of UTI
patients will contribute both to our understanding of UPEC
pathogenesis and to the development of effective UTI therapies.
Materials and Methods
Ethics statement
Non-pregnant women over the age of 18 years with symptoms
indicative of a UTI were invited to participate in our study by
A.L.L. or G.J.F. Written consent was obtained from all subjects
prior to enrollment and patient samples were assigned arbitrary
identification based on the order of enrollment in our study. All
human subject protocols were approved by the Institutional
Review Boards of the University of Michigan Medical School
(HUM00011155). All animal procedures were conducted in
accordance with the guidelines of the University Committee on
Use and Care of Animals at the University of Michigan Medical
School and following protocols approved by UCUCA.
Bacterial strains
Clinical E. coli isolates were cultured from the urine of women
with suspected UTIs using standard methods [82]. Antimicrobial
susceptibility testing was performed on all clinical E. coli isolates
cultured from the urine of the women participating in our study by
the Clinical Microbiology Laboratory at the University of
Michigan Health System using the VITEK 2 system (bioMerieux,
Durham, NC). Clinical isolates were serotyped by the E. coli
Reference Center at the Pennsylvania State University using
antisera against O1-O181 (except O31, O47, O72, O93, O94,
and O121, which were not designated) and PCR-restriction
fragment length polymorphism analysis of the fliC gene.
E. coli CFT073 was isolated from the blood and urine of a
patient with acute pyelonephritis and E. coli EFC4 was isolated
from the feces of a healthy woman with no history of a UTI or
antibiotic use in the previous six months [56]. E. coli K12 is the
prototypical commensal strain, MG1655 [83]. CFT073 type 1
fimbriae phase locked-on (L-ON) and locked-off (L-OFF) mutants
were constructed as previously described by our laboratory [84].
Strains were routinely cultured in Luria broth (10 g/L tryptone,
5 g/L yeast extract, 0.5 g/L NaCl) at 37uC with aeration, unless
otherwise noted.
Sample collection and in vivo RNA isolation
Fresh mid-stream urine was collected from consenting women
with presumptive bacteriuria attending the University of Michigan
Urology clinic. A diagnosis of presumptive bacteriuria was made
based on symptoms of urgency and frequency and/or a history of
previous UTI. Volumes collected ranged from 28 to 187 ml, with
a median volume of 70 ml (average=78.8 ml). Urine was
collected from 34 women in order to obtain 10 E. coli-positive
samples that were suitable for our study. Of these, two samples
contained multiple E. coli strains and were not analyzed further.
For the eight patients from whom single strains of E. coli were
isolated and studied in this report, no patient was catheterized.
Seven of eight patients reported a previous UTI. Two patients
were taking one antibiotic (ciprofloxacin or nitrofurantoin);
however, each respective E. coli strain was resistant to that
antibiotic.
Collected urine was immediately tested by urinalysis and
analyzed by wet-mount microscopy for the presence of bacteria.
Specimens positive for leukocyte esterase and/or nitrites, and/or
those containing visible bacteria by microscopy were immediately
stabilized (within 10 min of sample collection) by the addition of 2
volumes of RNAprotect (Qiagen) and incubated at 25uC for at
least 10 min. Stabilized urine specimens were collected by
centrifugation (30006g, 30 min, 25uC) and stabilized bacterial
pellets were stored at 280uC for up to four weeks. Upon receipt of
the clinical culture and sensitivity results, the E. coli-positive
samples were processed for RNA isolation using the RNeasy Mini
system (Qiagen) according to the manufacturer’s instructions.
DNA was removed from the preparation using TURBO DNase
(Ambion) and, where necessary, RNA samples were concentrated
using MinElute columns (Qiagen). It is important to note that
samples likely also contained human RNA, which was not
quantified or removed.
In vitro RNA isolation
Clinical E. coli isolates were cultured overnight in LB, washed
twice in pooled, filter-sterilized human urine (pooled from 5
healthy donors) and adjusted to OD600=4.0. Standardized
bacterial suspension was inoculated 1:100 into 25 ml human
urine (starting OD600=0.004) and cultured statically at 37uC until
OD600=0.260.02. Culture aliquots (5 ml) were stabilized with
10 ml RNAprotect and total RNA was isolated using the RNeasy
Mini procedure described above.
All RNA and cDNA preparations were analyzed using the
Agilent 2100 Bioanalyzer (Agilent Technologies) to verify sample
quality and integrity. Each sample met the criteria A260/A280$1.7
and A260/A230$1.5. Concentrations of total RNA and cDNA
samples were determined using a NanoDrop ND-1000 spectro-
photometer (Thermo Scientific).
cDNA synthesis, labeling and microarray hybridization
cDNA was synthesized from total RNA isolated using the
Superscript Double-Stranded cDNA Synthesis system (Invitrogen)
according to the manufacturer’s instructions. The only modifica-
tions to the protocol were an increase in random primer
concentration (3 mg) and extension of the reverse transcriptase
reaction (42uC, 90–120 min). cDNA was labeled and hybridized
by Roche NimbleGen (Madison, WI) according to their standard
protocols. Briefly, cDNA was labeled with Cy3 using the One-
Color DNA Labeling protocol (Roche NimbleGen) and 15 mg
labeled cDNA was prepared for each sample (10 in vivo samples
and 12 in vitro samples, each in triplicate microarrays). Following
hybridization, microarrays were washed and scanned using a
GenePix 4000B Scanner (Axon Instruments). Data were extracted
and analyzed using the Roche NimbleScan software, which
normalizes expression data using quantile normalization [85] and
generates gene calls using the Robust Multichip Average algorithm
[86].
E. coli CFT073 gene-specific microarray and data
normalization
The E. coli CFT073 microarray (Roche NimbleGen) contains 14
60-mer perfect match probes (no mismatch) for each of the 5379
open reading frames in the annotated CFT073 genome [14], as
well as random probes with similar G+C content. Each array value
for the 5379 genes was derived from the automated normalization
of 5 replicates of probes printed on each slide. The expression
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triplicate samples to the E. coli CFT073 microarray. Biological
replicates were not performed on the in vivo specimens as patients
commenced antibiotic therapy following consultation with G.J.F.
and the opportunity to collect multiple urine specimens was not
possible, therefore in vivo microarrays represent technical repli-
cates.
The median value of the three replicates was obtained for each
ORF and was compared to the median value of the random
probes on each chip. The median value of the random probes on
each array was used as a correction factor for the remaining signal
on the chip, normalizing the hybridization and RNA quality of
each preparation. The resulting absolute intensity values were
transformed into log2 values and subsequent analysis utilized these
log transformed normalized values to determine the potential
expression for any given gene represented on the array. The gene
was considered to be expressed if the intensity was four-fold above
the value of the randomized control values. It is important to note
that, as these isolates are uncharacterized, a lack of hybridization
does not always indicate that a gene is not expressed, only that
under the conditions examined there was not sufficient signal to
indicate expression. Gene absence or genetic divergence between
gene sequences of the isolates and gene sequences of the reference
strain, E. coli CFT073 may also explain poor hybridization. Gene
expression heat maps were generated using TreeView 1.60.
Microarray data have been deposited in NCBI Gene Expression
Omnibus [87] and are accessible through GEO Series accession
number GSE24478 (http://www.ncbi.nlm.nih.gov/geo/).
Invertible element assay
The orientation of the fim invertible element was determined as
described [73] using the primers listed in Table 5. Clinical isolates
and strain CFT073 were inoculated into 5 ml LB, incubated
statically at 37uC for 48 h, passaged 1:100 into fresh medium, and
incubated at 37uC for an additional 48 h. Aerated cultures were
similarly inoculated and incubated at 37uC for ,4 h. All cultures
were adjusted to OD600=1.0 and 500 ml was centrifuged
(10,0006g, 1 min) for western blotting (see below). Standardized
culture (50 ml) was added to 50 ml water and boiled 10 min. PCR
was performed to amplify the invertible element and 2 ml of crude
lysate as template. PCR product was digested with SnaBI and
separated on a 2% agarose gel.
Antisera production and western blotting
The fimA gene was cloned into the commercially-available
expression vector pBAD-myc-HisA (Invitrogen) in-frame with a C-
terminal His6 tag. Expression was induced by addition of L-
arabinose to 100 mM and recombinant protein was isolated on
nickel-nitriloacetic acid-agarose columns (Qiagen). Antibodies
were raised in rabbits against recombinant FimA-His6 excised
from SDS-PAGE gels by Rockland Immunochemicals, Inc.
(Gilbertsville, PA).
Bacterial pellets collected as described above were resuspended
100 ml acidified water (pH 1.8) and boiled for 10 min. Lysate was
mixed with 20 ml6 6SDS-PAGE loading buffer, neutralized with
1 N NaOH, and separated on 15% SDS-PAGE gels. Proteins were
transferred to PVDF membrane and blocked with 5% milk in TBS
+0.01% Tween-20. FimA was detected with rabbit anti-FimA
(1:2000), followed by anti-rabbit-HRP (1:25,000) and ECL Plus
detection reagents (GE Healthcare).
Hemagglutination
Strains were passaged statically or cultured with aeration as
described above and adjusted to OD600=0.8. One ml of culture
was pelleted (25006g,2m i n ,2 5 uC) and resuspended in 200 ml
PBS and serial dilutions of this bacterial suspension (25 ml) were
added to the wells of a microtiter plate. A 3% suspension of PBS-
washed guinea pig erythrocytes (v/v) was prepared in PBS on ice
and 25 ml added to each well. For testing mannose sensitivity,
erythrocyte suspension mixed with a-methyl mannoside (Sigma)
at 1 mg/ml was added to wells containing undiluted bacterial
suspension. Plates were gently rocked and incubated at 25uC
Table 5. Primers used in this study.
Gene Forward
a Reverse Reference
gapA ACGAAGTTGGTGTTGACGTTGTCG ATAACCACTTTCTTCGCACCAGCG [19]
fliC ACAGCCTCTCGCTGATCACTCAA GCGCTGTTAATACGCAAGCCAGAA [19]
fimA ACTCTGGCAATCGTTGTTCTGTCG ATCAACAGAGCCTGCATCAACTGC This study
papA2 ACGGGTGAAATTTGATGGAGCCAC AATTCGCAACTGCTGAGAAGGCAC This study
fyuA GCCATTGCTAATGCCCAGACTTCA AGATGAGACGTTGTTGGCTGATGC This study
hma ATCGTTCGGCAAGCAACCTTTG ATGCGGATTTGTTTACGGCCTG [89]
sat ACAATGTTGTCTCTGGCTGTTGCC GTGATTGTTACGTCTGTTGCTCCG This study
sisA CAGAATGCCCCGCGTAAGGC TTCCTGCAGTATATGGCGTGCCTGT [24]
glnA TTTGCGCTTCACCGATACCAAAGG TTAATGCCTTTCCAGCCGCCAATC This study
gdhA TCCTCGGCTTCGAACAAACCTTCA GGCAGAAACGCATAACTTCGCCTT This study
ackA AATGTTTCCACCTGCCCGAA AAAGTTGAGCGCTTCGCTGTGA This study
acs TAGCTATAAAGAGCTGCACCGCGA GCTTCCGGTACCATCGGCATATAA This study
rplQ TATGGCAGGTTCACTGGTTCGTCA TGGCAAGAGTAATCAGCGGCTCAA This study
msbB ATCGCTTTAACGCCGCCAAAGTTC TACGTTCTGGAAAGCAGAGCGACA This study
trkA GTGCGCGATGCCGATAAGCTATTT TCAGCGAAGTTCACCACCTGCAAT This study
fim IE
b AGTAATGCTGCTCGTTTTGC GACAGAGCCGACAGAACAAC [73]
aAll primers are listed 59R39.
bType 1 fimbrial invertible element.
doi:10.1371/journal.ppat.1001187.t005
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highest dilution of bacterial suspension that yielded a positive
reaction.
Mouse model of ascending UTI
Six- to eight-week female CBA/J mice were transurethrally
inoculated as previously described [34]. Clinical isolates were
cultured overnight in LB, collected by centrifugation (30006g,
30 min, 25uC) and resuspended in PBS to 2610
9 CFU/ml.
Bacterial suspension (50 ml/mouse) was delivered directly into the
bladders of anesthetized mice via a sterile 0.28 mm inner diameter
polyethylene catheter connected to an infusion pump (Harvard
Apparatus), with a total inoculum of 1610
8 CFU/mouse. At two-
hour intervals beginning at 5 h post-inoculation, urine was
collected and pooled from each cage of animals (5 mice).
Immediately after collection, cold 5% phenol-ethanol stop solution
was added, samples centrifuged (10,0006g, 1 min, 4uC), and
pellets stored at 280uC for RNA isolation. For CFU determina-
tion, mice were sacrificed at 48 hpi and urinary tract organs
homogenized with a GLH homogenizer (Omni International) in
3 ml PBS. Homogenate was plated on LB agar using an Autoplate
4000 spiral plater (Spiral Biotech) and colonies enumerated with a
QCount plate reader (Spiral Biotech). Significance was determined
using the two-tailed Mann-Whitney test.
qPCR
For microarray validation, real-time qPCR was performed with
cDNA isolated above for microarray hybridization. Reactions
were conducted in a Mx300P instrument (Stratagene), using 30 ng
cDNA template, 0.1 mM primers (Table 1), and Brilliant SYBR
Green reagents (Stratagene). Data were normalized to gapA and
analyzed with MxPro 4.0 software (Stratagene). For fimA
measurement at room temperature, CFT073 wildtype and L-
ON were cultured in 70 ml pooled, filter-sterilized human urine
for 6 h at 37uC. Cultures were decanted into 120 ml urine
collection cups with lids and incubated at room temperature for
60 min. At intervals, 1 ml culture aliquots were mixed with 125 ml
cold 5% phenol-ethanol stop solution, centrifuged (10,0006g,
1 min, 4uC), and stabilized pellets stored at 280uC. Thawed
pellets were resuspended in 100 ml 1 mg/ml lysozyme in TE and
RNA isolated using the RNeasy protocol as described above.
cDNA was synthesized using SuperScriptII First-Strand Synthesis
reagents according to the manufacturer’s instructions and qPCR
was performed as described.
Supporting Information
Table S1 Serotyping of clinical E. coli strains isolated from the
urine of women with presumptive UTIs.
Found at: doi:10.1371/journal.ppat.1001187.s001 (0.03 MB
DOC)
Table S2 Antibiotic resistance profiles of clinical E. coli strains
isolated from the urine of women with presumptive UTIs.
Found at: doi:10.1371/journal.ppat.1001187.s002 (0.03 MB
DOC)
Table S3 Gene expression summary for clinical E. coli strains
during in vivo and in vitro growth.
Found at: doi:10.1371/journal.ppat.1001187.s003 (0.03 MB
DOC)
Table S4 Hypothetical genes downregulated in vivo compared to
growth in human urine in vitro.
Found at: doi:10.1371/journal.ppat.1001187.s004 (0.06 MB
DOC)
Figure S1 UPEC expression of fimA following urine culture
transition to room temperature. Wildtype (white bars) or fim
Locked-ON (gray bars) CFT073 were cultured statically for ,6h
in 70 ml pooled human urine at 37uC. Cultures were decanted
into sterile 120 ml urine collection cups with lids and incubated at
room temperature. At the indicated timepoints, culture aliquots
were stabilized as described in the Methods and expression of fimA
was measured by qPCR (normalized to gapA). Mean relative
expression at each timepoint is shown relative to T0 and represents
three biological replicates from two independent experiments. The
right y-axis (black symbols) shows actual urine temperature
following transfer from 37uC to room temperature conditions.
Found at: doi:10.1371/journal.ppat.1001187.s005 (0.07 MB TIF)
Figure S2 Growth of clinical isolates under iron-limiting
conditions. Strains were iron-limited overnight in LB with 200
mM2 92-dipyridyl (DIP), washed in PBS, and inoculated 1:100 into
fresh (A) LB or LB containing (B) 200 mM or (C) 400 mM DIP.
Growth curves at 37uC are shown for CFT073 (black circles), K12
(black triangles), AL051 (red circles), AL121 (red triangles), AL151
(blue circles), AL231 (blue triangles), AL241 (green circles), AL291
(green triangles), AL361 (gray circles), and AL371 (gray triangles).
Found at: doi:10.1371/journal.ppat.1001187.s006 (0.18 MB TIF)
Figure S3 In vivo and in vitro expression of genes in the
yersiniabactin locus. Heat map indicates normalized microarray
signal intensities for genes encoding proteins involved in
yersiniabactin synthesis and transport in eight E. coli isolates
during UTI in patients (P) or culture in urine ex vivo (C). For
reference, the overall most (rpsK, +) and least (pheM, 2) expressed
genes are shown in the bottom panels, representing average signal
intensities of 15.821 and 3.881, respectively.
Found at: doi:10.1371/journal.ppat.1001187.s007 (0.15 MB TIF)
Figure S4 Sequence alignment of fimA and the invertible
element region. Sequences were aligned by ClustalW algorithm
using GraphPad Megalign software. ORFs (fimE and fimA) are
boxed and the left and right inverted repeat regions (IRL and IRR)
of the invertible element are in blue. Nucleotides differing from
CFT073 are shaded and percent nucleotide identities to CFT073
for each fimA ORF are indicated at the end of the sequence.
Found at: doi:10.1371/journal.ppat.1001187.s008 (1.07 MB
TIF)
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